Skip to main content
SpringerLink
Log in

Comparison of remimazolam and propofol in anesthetic management for awake craniotomy: a retrospective study

  • Clinical Report
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

A Correction to this article was published on 24 July 2023

This article has been updated

Abstract

A new ultra-short-acting benzodiazepine intravenous anesthetic agent, remimazolam, was launched in Japan in 2020. Anesthesia during awake craniotomy is reportedly being performed safely using remimazolam; however, studies on its efficacy in awake craniotomy have not been conducted. We aimed to compare the efficacy of remimazolam and propofol in awake craniotomy. In this retrospective study, patients who underwent awake craniotomy (n = 36) at our hospital between December 2019 and January 2021 were divided into two groups: the propofol group (P group: n = 21) and the remimazolam group (R group: n = 15). There was no significant difference in the recovery time between the two groups (p = 0.18). The number of patients experiencing nausea was higher in the R group than in the P group (p = 0.02); however, regression analysis revealed that the use of remimazolam contributed to increased intraoperative nausea (odds ratio = 14.4, p = 0.04). No significant differences were observed in the frequency of vomiting and other intraoperative complications between the two groups. In conclusion, remimazolam has the potential for use as an alternative drug in anesthetic management during awake craniotomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

References

  1. Lobo FA, Wagemakers M, Absalom AR. Anaesthesia for awake craniotomy. Br J Anaesth. 2016;116:740–4. https://doi.org/10.1093/bja/aew113.

    Article  CAS  PubMed  Google Scholar 

  2. Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anaesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34:543–53. https://doi.org/10.1007/s00540-020-02788-6.

    Article  PubMed  Google Scholar 

  3. Sato T, Kato Y, Yamamoto M, Nishiwaki K. Novel anesthetic agent remimazolam as an alternative for the asleep-awake-asleep technique of awake craniotomy. JA Clin Rep. 2020;6:92. https://doi.org/10.1186/s40981-020-00398-5.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sato T, Okumura T, Nishiwaki K. Preanesthesia scalp blocks reduce intraoperative pain and hypertension in the asleep-awake-asleep method of awake craniotomy: a retrospective study. J Clin Anesth. 2020;66: 109946. https://doi.org/10.1016/j.jclinane.2020.109946.

    Article  PubMed  Google Scholar 

  5. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8. https://doi.org/10.1038/bmt.2012.244.

    Article  CAS  PubMed  Google Scholar 

  6. Goettel N, Bharadwaj S, Venkatraghavan L, Mehta J, Bernstein M, Mannien PH. Dexmedetomidine vs propofol-remifentanil conscious sedation for awake craniotomy: a prospective randomized controlled trial. Br J Anaesth. 2016;116:811–21. https://doi.org/10.1093/bja/aew024.

    Article  CAS  PubMed  Google Scholar 

  7. Sneyd JR, Gambus PL, Rigby-Jones AE. Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative review. Br J Anaesth. 2021;127:41–55. https://doi.org/10.1016/j.bja.2021.03.028.

    Article  CAS  PubMed  Google Scholar 

  8. Yamamoto T, Kurabe M, Kamiya Y. Re-sleeping after reversal of remimazolam by flumazenil. J Anesth. 2021;35:322. https://doi.org/10.1007/s00540-021-02915-x.

    Article  PubMed  Google Scholar 

  9. Kamata K, Morioka N, Maruyama T, Komayama N, Nitta M, Muragaki Y, Kawamata T, Ozaki M. The effect of single low-dose dexamethasone on vomiting during awake craniotomy. J Anesth. 2016;30(6):941–8. https://doi.org/10.1007/s00540-016-2243-9.

    Article  PubMed  Google Scholar 

  10. Piccioni F, Fanzio M. Management of anesthesia in awake craniotomy. Minerva Anestesiol. 2008;74(7–8):393–408.

    CAS  PubMed  Google Scholar 

  11. Vasileiou I, Xanthos T, Koudouna E, Perrea D, Klonaris C, Katsargyris A, Papadimitriou L. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol. 2009;605:1–8. https://doi.org/10.1016/j.ejphar.2009.01.007.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Editage (https://www.editage.jp) for the English language review.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Nagoya University Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya City, Aichi, 466-8550, Japan

    Takehito Sato & Kimitoshi Nishiwaki

Authors
  1. Takehito Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kimitoshi Nishiwaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takehito Sato.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sato, T., Nishiwaki, K. Comparison of remimazolam and propofol in anesthetic management for awake craniotomy: a retrospective study. J Anesth 36, 152–155 (2022). https://doi.org/10.1007/s00540-021-03021-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-021-03021-8

Keywords

Search

Navigation